Windlas Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1031.55

+6.30 (+0.61%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1031.55

+6.30 (+0.61%)
16:02 Dec 20

Quality

75/100
High Financial Strength

Valuation

42/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	427.6	465.93	513.08	630.96	695.64
Operating Expenses +	372.91	413.5	452.86	552.79	609.4
Raw Material	270.74	307.56	340.71	386.59	450.3
Increase Decrease in Cost	3.67	-4.74	-15.27	9.59	-15.66
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	58.32	63.41	70.32	87.46	104.4
Miscellaneous Expenses	40.18	47.27	57.1	69.15	70.36
Operating Profit	54.69	52.43	60.22	78.17	86.24
Other Income	3.09	6.71	9.96	13.47	16.57
Depreciation	12.96	12.15	12.36	13.44	19.64
Interest	1.29	1.42	0.79	1.1	2.17
Profit before tax and exceptio..	43.53	45.56	57.04	77.09	81
Exceptional Items	-21.62	0	0	0	0
PBT	21.91	45.56	57.04	77.09	81
Provision for Taxation	6.17	7.48	14.41	18.9	19.81
Net Profit	15.74	38.09	42.63	58.19	61.23
NET Profit after MI	15.83	38.09	42.63	57.94	61.23
EPS	8.7	18.58	19.7	27.97	29.39
Operating Profit Margin (%)	12.79	11.25	11.74	12.39	12.4
Net Profit Margin (%)	3.7	8.18	8.31	9.18	8.8

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	62.50	62.50	62.80	62.80	62.80
FII	2.00	1.60	1.20	1.40	0.80
MF	7.60	8.70	10.40	10.40	10.40
Public	25.90	25.60	24.20	24.10	24.80
Others	0.00	0.00	0.00	0.00	0.10
Others	2.00	1.60	1.40	1.30	1.10